The cleavage of pro-urokinase type plasminogen activator by stromelysin-1

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 9, 1998, Pages 697-702

  Orgel, Dagmar ^a   Schröder, Werner ^b   Hecker Kia, Adelheid ^a   Weithmann, Klaus Ulrich ^c   Kolkenbrock, Hansjörg ^a   Ulbrich, Norbert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c SANOFI   (France)

Author keywords

Pro urokinase type plasminogen activator; Stromelysin 1 (MMP 3)

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MUTANT PROTEIN; NEUTROPHIL COLLAGENASE; PLASMIN; PROUROKINASE; SERINE PROTEINASE; STROMELYSIN; UROKINASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING;

ANIMALS; CATALYTIC DOMAIN; ENZYME PRECURSORS; HUMANS; HYDROLYSIS; MATRIX METALLOPROTEINASE 3; MOLECULAR WEIGHT; RABBITS; RECOMBINANT PROTEINS; SYNOVIAL MEMBRANE; URINARY PLASMINOGEN ACTIVATOR;

ORYCTOLAGUS CUNICULUS;

EID: 0345368036     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.123     Document Type: Article

References (29)

1. Mignatti P. Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney International 1995; 47: Suppl 49:12-4.
2. He C, Wilhelm SM, Pentland AP, Warmer BL, Grant JA, Eisen AZ, et al. GJ. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86:2632-6.
3. Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 1996 271:17124-31.
4. Ito A, Nagase H. Evidence, that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 1988; 267:211-6.
5. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP. Stromelysin is an activator for progelatinase. Biochem J 1987; 248: 265-8.
6. Ogata Y, Enghild J, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor of the human matrix metalloproteinase 9. J Biol Chem 1992; 267:3581-4.
7. Knäuper V, Wilhelm SM, Seperack PK, DeClerk YR, Langley KE, Osthues A, et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993; 295:581-6.
8. Kolkenbrock H, Hecker-Kia A, Orgel D, Huser H, Schröder W, Ulbrich N. Isolation of a latent 31-kDa C-truncated stromelysin and 21-kDa stromelysin from rabbit synovial fibroblasts: an alternative activation pathway for stromelysin. Biol Chem Hoppe Seyler 1994; 375:241-7.
9. Knäuper V, Lopez-Otin C, Smith B, Knight Murphy G. Biochemical characterisation of human collagenase-3. J Biol Chem 1996; 271:1544-50
10. Moscatelli D, Rifkin DB. Membrane and matrix localisation of proteinases: a common theme in tumor cell invasion. Biochem Biophys Acta 1988; 948: 67-85.
11. Barnathan ES, Kuo A, Rosenfeld L, Kariko K, Leski M, Robbiati F, et al. Interaction of single-chain urokinase type plasminogen activator with human endothelial cells. J Biol Chem 1990; 265:2865-72.
12. Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK. Differentiation enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci 1985; 82:4939-43.
13. Campbell IK, Piccoli DS, Butler DM, Singleton DK, Hamilton JA. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim Biophys Acta 1988; 967:183-94
14. Vitti G, Hamilton JA. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by IL-1a, retinoic acid and a glucocorticoid. Arthritis Rheum 1988; 31:1046-51.
15. Sumi H, Robbins KC. A functionally active heavy chain derived from human high molecular weight urokinase. J Biol Chem 1983; 258: 8014-9.
16. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K. Cellular receptor for urokinase plasminogen activator. J Biol Chem 1991; 266:1926-33.
17. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA.Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994; 269: 32380-8.
18. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 1996; 134:1563-71.
19. Marcotte PA, Dudlak D, Leski ML, Ryan J, Henkin J. Characterization of a metalloprotease which cleaves with high site specifity the Glu(143)-Leu(144) bond of urokinase. Fibrinolysis 1992; 6: Suppl 1: 57-62.
20. Marcotte PA, Kozan IM, Dorwin SA, Ryan JM. The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. J Biol Chem 1992; 267: 13803-6.
21. Brigelius-Flohe R, Steffens G, Strassburger W, Flohe L. High expression vectors for the production of recombinant single-chain urinary plasminogen activator from Escherichia coli. Appl Microbiol Biotechnol 1992; 36:640-9.
22. Kolkenbrock H, Hecker-Kia A Orgel D, Buchlow G, Sörensen H, Hauer W, Ulbrich N. A trypsin sensitive stromelysin isolated from rheumatoid synovial fluid is an activator for matrix-metalloproteinases. Eur J Clin Chem Clin Biochem 1993; 31: 625-31.
23. Ye QZ, Johnson LL, Hupe DJ, Baragi V. Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia coli. Biochemistry 1992; 31:11231-5.
24. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985; 260:2493-500.
25. Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDA progelatinase is a metalloproteinase inhibitor. Eur J Biochem 1991; 198:775-81.
26. Weithmann KU, Schlotte V, Jeske V, Seiffge D, Laber A, Haase B, Schleyerbach R. Effects of tiaprofenic acid on urinary pyridinium crosslinks in adjuvant arthritic rats: comparison with doxycycline. Inflamm Res 1997; 46:246-52.
27. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992; 296:263-6.
28. Nagase H, Fields CG, Fields BG. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix-metalloproteinase-3). J Biol Chem 1994; 269:20952-57.
29. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol 1995; 154:6484-91.